Updates on Radiotherapy for Localized Prostate Cancer
Radiotherapy is one modality of radical therapy for patients with localized prostate cancer without severe complications. Traditionally, it has been given with a conventionally fractionated schedule over several weeks; however, moderate hypofractionation has emerged as a standard of care over the pa...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2023-12-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2023.16.114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Radiotherapy is one modality of radical therapy for patients with localized prostate cancer without severe complications. Traditionally, it has been given with a conventionally fractionated schedule over several weeks; however, moderate hypofractionation has emerged as a standard of care over the past few years, based on data from large randomized studies.^1-4^ Another important topic in this clinical setting is elective irradiation of the pelvic lymphatics but clinical data and guideline recommendations remain uncertain.^5-8^ Radiotherapy is also associated with a different spectrum of side effects than surgery or active monitoring,^9,10^ which can, alongside efficacy outcomes, have a substantial impact on decision-making. This article summarizes data on these important issues in prostate cancer management, including recent updates.
PEER REVIEWED ARTICLE |
|---|---|
| ISSN: | 2673-2106 |